Abstract
The Aurora kinases play a key role in mitosis and are overexpressed in multiple human tumor types; there has been considerable interest in developing Aurora kinase inhibitors as antitumor agents, particularly Aurora A and Aurora B kinases. A series of novel hydrazide hydrochlorides of pyrazolo[1,5-a]pyrimidine carboxamides were designed and synthesized and their inhibitory activities against Aurora kinases were evaluated. Some of the tested compounds exhibited low micromolar to nanomolar activity with respect to the inhibition of Aurora A kinase. The most potent compound in this series was found to be a potent inhibitor of Aurora A in an HTRF enzymatic assay with an IC50 as low as 23 nM. A structure–activity relationship study indicated that halogen substitution in the benzene ring of amide plays an important role in kinase inhibitory potency.
Graphical abstract
Similar content being viewed by others
References
Fu J, Bian M, Jiang Q, Zhang C (2007) Mol Cancer Res 5:1
Pollard JR, Mortimore M (2009) J Med Chem 52:2629
Carvajal RD, Tse A, Schwartz GK (2006) Clin Cancer Res 12:6869
Katayama H, Brinkley WR, Sen S (2003) Cancer Metastasis Rev 22:451
Ota T, Suto S, Katayama H, Han ZB, Suzuki F, Maeda M, Tanino M, Terada Y, Tatsuka M (2002) Cancer Res 62:5168
Carmena M, Earnshaw WC (2003) Nat Rev Mol Cell Biol 4:842
Marumoto T, Zhang D, Saya H (2005) Nat Rev Cancer 5:42
Harrington EA, Bebbington D, Moore J, Rasmussen RK, Ajose-Adeogun AO, Nakayama T, Graham JA, Demur C, Hercend T, Diu-Hercend A, Su M, Golec JM, Miller KM (2004) Nat Med 10:262
Oslob JD, Yu CH (2007) Pyrazolopyrimidines useful as Aurora kinase inhibitors and their preparation, pharmaceutical compositions and use in the treatment of Aurora kinase mediated diseases. Patent WO2007013964, Feb 1, 2007
Lew W, Baskaran S, Oslob JD, Yoburn JC, Zhong M (2006) Thienopyrimidines useful as Aurora kinase inhibitors and their preparation, pharmaceutical compositions, and their use for treatment of Aurora kinase-mediated diseases. Patent WO2006036266, Apr 6, 2006
Sloane DA, Trikic MZ, Chu ML, Lamers MB, Mason CS, Mueller I, Savory WJ, Williams DH, Eyers PA (2010) ACS Chem Biol 5:563
Shimomura T, Hasako S, Nakatsuru Y, Mita T, Ichikawa K, Kodera T, Sakai T, Nambu T, Miyamoto M, Takahashi I, Miki S, Kawanishi N, Ohkubo M, Kotani H, Iwasawa Y (2010) Mol Cancer Ther 9:157
Mortlock AA, Foote KM, Heron NM, Jung FH, Pasquet G, Lohmann JJ, Warin N, Renaud F, De-Savi C, Roberts NJ, Johnson T, Dousson CB, Hill GB, Perkins D, Hatter G, Wilkinson RW, Wedge SR, Heatson SP, Odedra R, Keen NJ, Crafter C, Brown E, Thompson K, Brightwell S, Khatri L, Brady MC, Kearney S, McKillop D, Rhead S, Parry T, Green S (2007) J Med Chem 50:2213
Carpinelli P, Ceruti R, Giorgini ML, Cappella P, Gianellini L, Croci V, Degrassi A, Texido G, Rocchetti M, Vianello P, Rusconi L, Storici P, Zugnoni P, Arrigoni C, Soncini C, Alli C, Patton V, Marsiglio A, Ballinari D, Pesenti E, Fancelli D, Moll J (2007) Mol Cancer Ther 6:3158
Bavetsias V, Linardopoulos S (2015) Front Oncol 5:278
Falchook GS, Bastida CC, Kurzrock R (2015) Semin Oncol 42:832
McCall JM, Kelly RC, Romero DL (2012) Pyrazolopyrimidinone compounds for the inhibition of PASK and their preparation. Patent WO2012149157, Nov 1, 2012
Rajadhyaksha MN, Kolekar SL, Baviskar AY, Panandikar AM (2011) Process for the preparation of a pyrazole derivative. Patent WO2011064798, Jun 3, 2011
Kumar AKA, Nair KB, Bodke YD, Sambasivam G, Bhat KG (2016) Monatsh Chem 147:2221
Bremberg U, Linden A, Lundback T, Nilsson J, Wiik M, Bergner M, Brandt P, Hammer K, Ringom R (2008) Preparation of pyrazolo[1,5-a]pyrimidines as inhibitors of stearoyl-CoA desaturase. Patent WO 2008116898, Oct 2, 2008. Chem Abstr 149:425–961
Lees S, Jorgensen M, Hartwig JF (2001) Org Lett 3:2729
Huang X, Buchwald SL (2001) Org Lett 3:3417
Vo GD, Hartwig JF (2009) J Am Chem Soc 131:11049
Acknowledgements
We are thankful to Anthem Biosciences management, Anthem Biosciences, Bangalore, India, for their invaluable support and allocation of resources for this work. We would like to thank Analytical chemistry team, Department of Analytical Chemistry, Anthem Biosciences, Bangalore, India, for having carried out all the analytical work. Also, we would like to thank molecular biology team, Department of Molecular Biology, Anthem Biosciences, Bangalore, India, for executing the Aurora Kinase activity studies.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Kumar, A.K.A., Bodke, Y.D., Sambasivam, G. et al. Design, synthesis, and evaluation of novel hydrazide hydrochlorides of 6-aminopyrazolo[1,5-a]pyrimidine-3-carboxamides as potent Aurora kinase inhibitors. Monatsh Chem 148, 1767–1780 (2017). https://doi.org/10.1007/s00706-017-1943-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00706-017-1943-7